| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |